Malathion exposure modulates hypothalamic gene expression and induces dyslipedemia in Wistar rats

Food and Chemical Toxicology

Volumn 48, Issue 6, 2010, Pages 1473-1477

  Rezg, Raja ^a   Mornagui, Bessem ^a   Benahmed, Malika ^b   Gharsalla Chouchane, Sonia ^a   Belhajhmida, Nadia ^b   Abdeladhim, Maha ^b   Kamoun, Abdelaziz ^a   El fazaa, Saloua ^a   Gharbi, Najoua ^a  

^a FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^b PASTEUR INSTITUTE OF TUNIS   (Tunisia)

Author keywords

Corticotropin releasing hormone; Diabetes type 2; Inducible NO synthase dyslipedemia; Malathion; Risk factor

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID; INDUCIBLE NITRIC OXIDE SYNTHASE; MALATHION; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DYSLIPIDEMIA; GENE EXPRESSION; HYPERTRIGLYCERIDEMIA; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN RESISTANCE; LIPID METABOLISM; MALE; NEGATIVE FEEDBACK; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; RAT;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DYSLIPIDEMIAS; GENE EXPRESSION REGULATION; HYPOTHALAMUS; MALATHION; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; RNA, MESSENGER;

RATTUS; RATTUS NORVEGICUS;

EID: 77952882470     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.03.013     Document Type: Article

References (48)

1. Bredt D.S., Glatt C.E., Hwang P.M., Fotuhi M., Dawson T.M., Snyder S.H. Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 1991, 7:615-624.
2. Choudhary N., Goyal R., Joshi S.C. Effect of malathion on reproductive system of male rats. J. Environ. Biol. 2008, 29:259-262.
3. Clement J.G. Hormonal consequences of organophosphate poisoning. Fund. Appl. Toxicol. 1985, 5:S61-77.
4. Dallman M.F., Akana S.F., Cascio C.S., Darlington D.N., Jacobson L., Levin N. Regulation of ACTH secretion: variations on a theme of B. Recent Prog. Horm. Res. 1987, 43:113-173.
5. De Kloet E.R., Vreugdenhil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 1998, 19:269-301.
6. Delarue J., Magnan C. Free fatty acids and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 2007, 10:142-148.
7. Galloway T., Handy R. Immunotoxicity of organophosphorous pesticides. Ecotoxicology 2003, 12:345-363.
8. Givalois L., Arancibia S., Tapia-Arancibia L. Concomitant changes in CRH mRNA levels in rat hippocampus and hypothalamus following immobilization stress. Brain Res. Mol. Brain Res. 2000, 75:166-171.
9. Hazarika A., Sarkar S.N., Hajare S., Kataria M., Malik J.K. Influence of malathion pretreatment on the toxicity of anilofos in male rats: a biochemical interaction study. Toxicology 2003, 185:1-8.
10. IPCS, 1996. IPCS, International Programme on Chemical Safety. The WHO Recommended Classification of Pesticides by Hazard and Guidelines to Classification 1996-1997. Organisation Mondiale de la santé, Genève, WHO/PCS/96.3.
11. Ixart G., Alonso G., Szafarczyk A., Malaval F., Nouguier-Soule J., Assenmacher I. Adrenocorticotropic regulations after bilateral lesions of the paraventricular or supraoptic nuclei and in Brattleboro rats. Neuroendocrinology 1982, 35:270-276.
12. Ji J.Y., Diamond S.L. Exogenous nitric oxide activates the endothelial glucocorticoid receptor. Biochem. Biophys. Res. Commun. 2004, 318:192-197.
13. Johren O., Dendorfer A., Dominiak P., Raasch W. Gene expression of mineralocorticoid and glucocorticoid receptors in the limbic system is related to type-2 like diabetes in leptin-resistant rats. Brain Res. 2007, 1184:160-167.
14. Joshi A.K., Rajini P.S. Reversible hyperglycemia in rats following acute exposure to acephate, an organophosphorus insecticide: role of gluconeogenesis. Toxicology 2009, 257:40-45.
15. Kakui N., Kitamura K. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway. Endocrinology 2007, 148:2854-2862.
16. Kim J.K., Fillmore J.J., Chen Y., Yu C., Moore I.K., Pypaert M., Lutz E.P., Kako Y., Velez-Carrasco W., Goldberg I.J., Breslow J.L., Shulman G.I. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci USA 2001, 98:7522-7527.
17. Kretz O., Reichardt H.M., Schutz G., Bock R. Corticotropin-releasing hormone expression is the major target for glucocorticoid feedback-control at the hypothalamic level. Brain Res. 1999, 818:488-491.
18. Krishnan A.V., Zhao X.Y., Swami S., Brive L., Peehl D.M., Ely K.R., Feldman D. A glucocorticoid-responsive mutant androgen receptor exhibits unique ligand specificity: therapeutic implications for androgen-independent prostate cancer. Endocrinology 2002, 143:1889-1900.
19. Kuhn C.M., Bartolome M. Effect of chronic methadone administration on neuroendocrine function in developing rats. Dev. Pharmacol. Therap. 1984, 7:384-397.
20. Lamas S., Marsden P.A., Li G.K., Tempst P., Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc. Natl. Acad. Sci. USA 1992, 89:6348-6352.
21. Lassiter T.L., Ryde I.T., Mackillop E.A., Brown K.K., Levin E.D., Seidler F.J., Slotkin T.A. Exposure of neonatal rats to parathion elicits sex-selective reprogramming of metabolism and alters the response to a high-fat diet in adulthood. Environ. Health Perspect. 2008, 116:1456-1462.
22. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991, 43:109-142.
23. Montgomery M.P., Kamel F., Saldana T.M., Alavanja M.C., Sandler D.P. Incident diabetes and pesticide exposure among licensed pesticide applicators: Agricultural Health Study, 1993-2003. Am. J. Epidemiol. 2008, 167:1235-1246.
24. Mountjoy K.G., Wong J. Obesity, diabetes and functions for proopiomelanocortin-derived peptides. Mol. Cell. Endocrinol. 1997, 128:171-177.
25. Muglia L.J., Bethin K.E., Jacobson L., Vogt S.K., Majzoub J.A. Pituitary-adrenal axis regulation in CRH-deficient mice. Endocr. Res. 2000, 26:1057-1066.
26. Muglia L.J., Jacobson L., Weninger S.C., Luedke C.E., Bae D.S., Jeong K.H., Majzoub J.A. Impaired diurnal adrenal rhythmicity restored by constant infusion of corticotropin-releasing hormone in corticotropin-releasing hormone-deficient mice. J. Clin. Invest. 1997, 99:2923-2929.
27. Nathan C., Xie Q.W. Nitric oxide synthases: roles, tolls, and controls. Cell 1994, 78:915-918.
28. Nathan C., Xie Q.W. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 1994, 269:13725-13728.
29. Osicka-Koprowska A., Lipska M., Wysocka-Paruszewska B. Effects of chlorfenvinphos on plasma corticosterone and aldosterone levels in rats. Arch. Toxicol. 1984, 55:68-69.
30. Özme G., Akay M.T. The effects of malathion on some hormones and tissues secreting these hormones in rats. Vet. Hum. Toxicol. 1993, 35(1):22-24.
31. Pournourmohammadi S., Farzami B., Ostad S., Azizi E., Abdollahi M. Effects of malathion subchronic exposure on rat skeletal muscle glucose metabolism. Environ. Toxicol. Pharmacol. 2005, 19:191-196.
32. Pournourmohammadi S., Ostad S.N., Azizi E., Hossein Ghahremani M., Farzami B., Minaie B., Larijani B., Abdollahi M. Induction of insulin resistance by malathion; evidence for disturbed islets cells metabolism and mitochondrial dysfunction. Pestic. Biochem. Physiol. 2007, 88:346-352.
33. Rahimi R., Abdollahi M. A review on the mechanisms involved in hyperglycemia induced by organophosphorus pesticides. Pestic. Biochem. Physiol. 2007, 88:115-121.
34. Rett K. The relation between insulin resistance and cardiovascular complications of the insulin resistance syndrome. Diabetes Obes. Metab. 1999, 1(Suppl. 1):S8-S16.
35. Rezg R., Mornagui B., El-Arbi M., Kamoun A., El-Fazaa S., Gharbi N. Effect of subchronic exposure to malathion on glycogen phosphorylase and hexokinase activities in rat liver using native PAGE. Toxicology 2006, 223:9-14.
36. Rezg R., Mornagui B., El-Fazaa S., Gharbi N. Biochemical evaluation of hepatic damage in subchronic exposure to malathion in rats: effect on superoxide dismutase and catalase activities using native PAGE. C. R. Biol. 2008, 331:655-662.
37. Rezg R., Mornagui B., El-Fazaa S., Gharbi N. Caffeic acid attenuates malathion induced metabolic disruption in rat liver, involvement of acetylcholinesterase activity. Toxicology 2008, 250:27-31.
38. Rezg R., Mornagui B., Kamoun A., El-Fazaa S., Gharbi N. Effect of subchronic exposure to malathion on metabolic parameters in the rat. C. R. Biol. 2007, 330:143-147.
39. Schwartz M.W., Strack A.M., Dallman M.F. Evidence that elevated plasma corticosterone levels are the cause of reduced hypothalamic corticotrophin-releasing hormone gene expression in diabetes. Regul. Peptides 1997, 72:105-112.
40. Smallridge R.C., Carr F.E., Fein H.G. Diisopropylfluorophosphate (DFP) reduces serum prolactin, thyrotropin, luteinizing hormone, and growth hormone and increases adrenocorticotropin and corticosterone in rats: involvement of dopaminergic and somatostatinergic as well as cholinergic pathways. Toxicol. Appl. Pharmacol. 1991, 108:284-295.
41. Spassova D., White T., Singh A.K. Acute effects of acephate and methamidophos on acetylcholinesterase activity, endocrine system and amino acid concentrations in rats. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2000, 126:79-89.
42. Tasker J.G. Rapid glucocorticoid actions in the hypothalamus as a mechanism of homeostatic integration. Obesity (Silver Spring) 2006, 14(Suppl. 5):259S-265S.
43. Uribe R.M., Lee S., Rivier C. Endotoxin stimulates nitric oxide production in the paraventricular nucleus of the hypothalamus through nitric oxide synthase I: correlation with hypothalamic-pituitary-adrenal axis activation. Endocrinology 1999, 140:5971-5981.
44. Vincent S.R. Nitric oxide: a radical neurotransmitter in the central nervous system. Prog. Neurobiol. 1994, 42:129-160.
45. Watts A.G., Tanimura S., Sanchez-Watts G. Corticotropin-releasing hormone and arginine vasopressin gene transcription in the hypothalamic paraventricular nucleus of unstressed rats: daily rhythms and their interactions with corticosterone. Endocrinology 2004, 145:529-540.
46. Whitnall M.H. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog. Neurobiol. 1993, 40:573-629.
47. Wynn P.C., Hauger R.L., Holmes M.C., Millan M.A., Catt K.J., Aguilera G. Brain and pituitary receptors for corticotropin releasing factor: localization and differential regulation after adrenalectomy. Peptides 1984, 5:1077-1084.
48. Yao M., Denver R.J. Regulation of vertebrate corticotropin-releasing factor genes. Gen. Comp. Endocrinol. 2007, 153:200-216.